Addington, D, Addington, J and Schissel, B (1990) A depression rating scale for schizophrenics. Schizophrenia Research 3, 247–251.
Addington, D, Addington, J and Patten, S (1998) Depression in people with first-episode schizophrenia. The British Journal of Psychiatry 172, 90–92.
Addington, J, van Mastrigt, S, Hutchinson, J and Addington, D (2002) Pathways to care: help seeking behaviour in first episode psychosis. Acta Psychiatrica Scandinavica 106, 358–364.
Allott, KA, Yuen, HP, Garner, B, Bendall, S, Killackey, EJ, Alvarez-Jimenez, M, Phassouliotis, C, Markulev, C, Yun, Y, McGorry, PD and Phillips, LJ (2013) Relationship between vocational status and perceived stress and daily hassles in first-episode psychosis: an exploratory study. Social Psychiatry and Psychiatric Epidemiology 48, 1045–1052.
Arranz, B, San, L, Ramirez, N, Duenas, R, Perez, V, Salavert, J, Corripio, I and Alvarez, E (2009) Clinical and serotonergic predictors of non-affective acute remitting psychosis in patients with a first-episode psychosis. Acta Psychiatrica Scandinavica 119, 71–77.
Arrasate, M, Gonzalez-Ortega, I, Alberich, S, Gutierrez, M, Martinez-Cengotitabengoa, M, Mosquera, F, Cruz, N, Gonzalez-Torres, M, Henry, C and Gonzalez-Pinto, A (2014) Affective dimensions as a diagnostic tool for bipolar disorder in first psychotic episodes. European Psychiatry 29, 424–430.
Barrett, EA, Sundet, K, Faerden, A, Agartz, I, Bratlien, U, Romm, KL, Mork, E, Rossberg, JI, Steen, NE, Andreassen, OA and Melle, I (2010) Suicidality in first episode psychosis is associated with insight and negative beliefs about psychosis. Schizophrenia Research 123, 257–262.
Bath, PA, Deeg, D and Popellaars, J (2010) The harmonisation of longitudinal data: a case study using data from cohort studies in The Netherlands and the United Kingdom. Ageing and Society 30, 1419–1437.
Bendall, S, Allott, K, Johnson, T, Jackson, HJ, Killackey, E, Harrigan, S and McGorry, PD (2008) Pattern of lifetime axis I morbidity among a treated sample of first-episode psychosis patients. Psychopathology 41, 90–95.
Bertelsen, M, Jeppesen, P, Petersen, L, Thorup, A, Ohlenschlaeger, J, le Quach, P, Christensen, TO, Krarup, G, Jorgensen, P and Nordentoft, M (2007) Suicidal behaviour and mortality in first-episode psychosis: the OPUS trial. British Journal of Psychiatry – Supplementum 51, s140–s146.
Binder, J, Albus, M, Hubmann, W, Scherer, J, Sobizack, N, Franz, U, Mohr, F and Hecht, S (1998) Neuropsychological impairment and psychopathology in first-episode schizophrenic patients related to the early course of illness [Erratum appears in Eur Arch Psychiatry Clin Neurosci 1998;248(4):212]. European Archives of Psychiatry & Clinical Neuroscience 248, 70–77.
Birchwood, M, Iqbal, Z and Upthegrove, R (2005) Psychological pathways to depression in schizophrenia: studies in acute psychosis, post psychotic depression and auditory hallucinations. European Archives of Psychiatry and Clinical Neuroscience 255, 202–212.
Chang, WC, Pang, SL, Chung, DW and Chan, SS (2009) Five-year stability of ICD-10 diagnoses among Chinese patients presented with first-episode psychosis in Hong Kong. Schizophrenia Research 115, 351–357.
Chang, WC, Hui, CLM, Tang, JYM, Wong, GH, Lam, MM, Chan, SK and Chen, EYH (2011) Persistent negative symptoms in first-episode schizophrenia: a prospective three-year follow-up study. Schizophrenia Research 133, 22–28.
Chang, WC, Chen, ESM, Hui, CLM, Chan, SKW, Lee, EHM and Chen, EYH (2014) The relationships of suicidal ideation with symptoms, neurocognitive function, and psychological factors in patients with first-episode psychosis. Schizophrenia Research 157, 12–18.
Chang, WC, Cheung, R, Hui, CLM, Lin, JX, Chan, SKW, Lee, EHM and Chen, EYH (2015) Rate and risk factors of depressive symptoms in Chinese patients presenting with first-episode non-affective psychosis in Hong Kong. Schizophrenia Research 168, 99–105.
Chang, WC, Kwong, VWY, Chan, GHK, Jim, OTT, Lau, ESK, Hui, CLM, Chan, SKW, Lee, EHM and Chen, EYH (2017) Prediction of motivational impairment: 12-month follow-up of the randomized-controlled trial on extended early intervention for first-episode psychosis. European Psychiatry 41, 37–41.
Chen, DC, Wang, J, Wang, B, Yang, SC, Zhang, CX, Zheng, YL, Li, YL, Wang, N, Yang, KB, Xiu, MH, Kosten, TR and Zhang, XY (2009) Decreased levels of serum brain-derived neurotrophic factor in drug-naive first-episode schizophrenia: relationship to clinical phenotypes. Psychopharmacology 207, 375–380.
Chiappelli, J, Nugent, KL, Thangavelu, K, Searcy, K and Hong, LE (2014) Assessment of trait and state aspects of depression in schizophrenia. Schizophrenia Bulletin 40, 132–142.
Coentre, R, Talina, MC, Gois, C and Figueira, ML (2017) Depressive symptoms and suicidal behavior after first-episode psychosis: a comprehensive systematic review. Psychiatry Research 253, 240–248.
Conley, RR, Ascher-Svanum, H, Zhu, B, Faries, DE and Kinon, BJ (2007) The burden of depressive symptoms in the long-term treatment of patients with schizophrenia. Schizophrenia Research 90, 186–197.
Cotton, S, Gleeson, J, Alvarez-Jimenez, M and McGorry, P (2010) Quality of life in patients who have remitted from their first episode of psychosis. Schizophrenia Research 121, 259–265.
Cotton, S, Lambert, M, Schimmelmann, B, Mackinnon, A, Gleeson, J, Berk, M, Hides, L, Chanen, A, McGorry, P and Conus, P (2012) Depressive symptoms in first episode schizophrenia spectrum disorder. Schizophrenia Research 134, 20–26.
Cotton, SM, Lambert, M, Schimmelmann, BG, Mackinnon, A, Gleeson, JFM, Berk, M, Hides, L, Chanen, AM, Scott, J, Schottle, D, McGorry, PD and Conus, P (2013) Differences between first episode schizophrenia and schizoaffective disorder. Schizophrenia Research 147, 169–174.
Dai, J, Du, X, Yin, G, Zhang, Y, Xia, H, Li, X, Cassidy, R, Tong, Q, Chen, D, Teixeira, AL, Zheng, Y, Ning, Y, Soares, JC, He, M and Zhang, XY (2017) Prevalence, demographic and clinical features of comorbid depressive symptoms in drug naive patients with schizophrenia presenting with first episode psychosis. Schizophrenia Research 193, 182–187.
Ebdrup, BH, Raghava, JM, Nielsen, MO, Rostrup, E and Glenthoj, B (2016) Frontal fasciculi and psychotic symptoms in antipsychotic-naive patients with schizophrenia before and after 6 weeks of selective dopamine D2/3 receptor blockade. Journal of Psychiatry and Neuroscience 41, 133–141.
Emsley, R, Asmal, L, du Plessis, S, Chiliza, B, Kidd, M, Carr, J and Vink, M (2015) Dorsal striatal volumes in never-treated patients with first-episode schizophrenia before and during acute treatment. Schizophrenia Research 169, 89–94.
Garcia, M, Montalvo, I, Creus, M, Cabezas, A, Sole, M, Algora, MJ, Moreno, I, Gutierrez-Zotes, A and Labad, J (2016) Sex differences in the effect of childhood trauma on the clinical expression of early psychosis. Comprehensive Psychiatry 68, 86–96.
Gonzalez-Ortega, I, Alberich, S, Echeburua, E, Aizpuru, F, Millan, E, Vieta, E, Matute, C and Gonzalez-Pinto, A (2015) Subclinical depressive symptoms and continued cannabis use: predictors of negative outcomes in first episode psychosis. PLoS ONE 10, 1–12.
Gregory, A, Mallikarjun, P and Upthegrove, R (2017) Treatment of depression in schizophrenia: systematic review and meta-analysis. British Journal of Psychiatry 211, 198–204.
Helfer, B, Samara, MT, Huhn, M, Klupp, E, Leucht, C, Zhu, Y, Engel, RR and Leucht, S (2016) Efficacy and safety of antidepressants added to antipsychotics for schizophrenia: a systematic review and meta-analysis. American Journal of Psychiatry 173, 876–886.
Herniman, S, Allott, K, Killackey, E, Hester, R and Cotton, S (2017) The psychometric validity of the Center for Epidemiological Studies-Depression Scale (CES-D) in first episode schizophrenia spectrum. Psychiatry Research 252, 16–22.
Jager, M, Haack, S, Becker, T and Frasch, K (2011) Schizoaffective disorder – an ongoing challenge for psychiatric nosology. European Psychiatry 26, 159–165.
Kampman, O, Kiviniemi, P, Koivisto, E, Vaananen, J, Kilkku, N, Leinonen, E and Lehtinen, K (2004) Patient characteristics and diagnostic discrepancy in first-episode psychosis. Comprehensive Psychiatry 45, 213–218.
Koreen, AR, Siris, SG, Chakos, M, Alvir, J, Mayerhoff, D and Lieberman, J (1993) Depression in first-episode schizophrenia. American Journal of Psychiatry 150, 1643–1648.
Kraemer, HC, Noda, A and O'Hara, R (2004) Categorical versus dimensional approaches to diagnosis: methodological challenges. Journal of Psychiatric Research 38, 17–25.
Lee, SJ, Kim, KR, Lee, SY and An, SK (2017) Impaired social and role function in ultra-high risk for psychosis and first-episode schizophrenia: its relations with negative symptoms. Psychiatry Investigation 14, 539–545.
Majadas, S, Olivares, J, Galan, J and Diez, T (2012) Prevalence of depression and its relationship with other clinical characteristics in a sample of patients with stable schizophrenia. Comprehensive Psychiatry 53, 145–151.
McGorry, PD and Yung, AR (2003) Early intervention in psychosis: an overdue reform. Australian and New Zealand Journal of Psychiatry 37, 393–398.
Minor, KS, Friedman-Yakoobian, M, Leung, Y, Meyer, EC, Zimmet, SV, Caplan, B, Monteleone, T, Bryant, C, Guyer, M, Keshavan, MS and Seidman, LJ (2015) The impact of premorbid adjustment, neurocognition, and depression on social and role functioning in patients in an early psychosis treatment program. Australian and New Zealand Journal of Psychiatry 49, 444–452.
Moher, D, Shamseer, L, Clarke, M, Ghersi, D, Liberati, A, Petticrew, M, Shekelle, P and Stewart, LA and PRISMA-P Group (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic Reviews 4, 1–9.
Mutsatsa, SH, Joyce, EM, Hutton, SB and Barnes, TR (2006) Relationship between insight, cognitive function, social function and symptomatology in schizophrenia: the west London first episode study. European Archives of Psychiatry and Clinical Neuroscience 256, 356–363.
Noto, C, Ota, VK, Santoro, ML, Ortiz, BB, Rizzo, LB, Higuchi, CH, Cordeiro, Q, Belangero, SI, Bressan, RA, Gadelha, A, Maes, M and Brietzke, E (2015) Effects of depression on the cytokine profile in drug naive first-episode psychosis. Schizophrenia Research 164, 53–58.
O'Callaghan, E, Turner, N, Renwick, L, Jackson, D, Sutton, M, Foley, SD, McWilliams, S, Behan, C, Fetherstone, A and Kinsella, A (2010) First episode psychosis and the trail to secondary care: help-seeking and health-system delays. Social Psychiatry and Psychiatric Epidemiology 45, 381–391.
Ohmuro, N, Matsumoto, K, Katsura, M, Obara, C, Kikuchi, T, Hamaie, Y, Sakuma, A, Iizuka, K, Ito, F and Matsuoka, H (2015) The association between cognitive deficits and depressive symptoms in at-risk mental state: a comparison with first-episode psychosis. Schizophrenia Research 162, 67–73.
Oosthuizen, P, Emsley, RA, Roberts, MC, Turner, J, Keyter, L, Keyter, N and Torreman, M (2002) Depressive symptoms at baseline predict fewer negative symptoms at follow-up in patients with first-episode schizophrenia. Schizophrenia Research 58, 247–252.
Pawelczyk, T, Grancow-Grabka, M, Kotlicka-Antczak, M, Trafalska, E and Pawelczyk, A (2016) A randomized controlled study of the efficacy of six-month supplementation with concentrated fish oil rich in omega-3 polyunsaturated fatty acids in first episode schizophrenia. Journal of Psychiatric Research 73, 34–44.
Pena, J, Ojeda, N, Segarra, R, Eguiluz, JI, Garcia, J and Gutierrez, M (2011) Executive functioning correctly classified diagnoses in patients with first-episode psychosis: evidence from a 2-year longitudinal study. Schizophrenia Research 126, 77–80.
Potvin, S, Sepehry, AA and Stip, E (2007) Meta-analysis of depressive symptoms in dual-diagnosis schizophrenia. Australian and New Zealand Journal of Psychiatry 41, 792–799.
Riedel, M, Mayr, A, Seemller, F, Maier, W, Klingberg, S, Heuser, I, Klosterkotter, J, Gastpar, M, Schmitt, A, Sauer, H, Schneider, F, Gaebel, W, Jger, M, Moller, HJ and Schennach-Wolff, R (2012) Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidol. World Journal of Biological Psychiatry 13, 30–38.
Roche, E, Clarke, M, Browne, S, Turner, N, McTuige, O, Kamali, M, Kinsellla, A, Larkin, C, Waddington, JL and O'Callaghan, E (2010) Prevalence and clinical correlates of depression in the acute phase of first episode schizophrenia. Irish Journal of Psychological Medicine 27, 15–18.
Romm, KL, Rossberg, JI, Berg, AO, Barrett, EA, Faerden, A, Agartz, I, Andreassen, OA and Melle, I (2010) Depression and depressive symptoms in first episode psychosis. Journal of Nervous and Mental Disease 198, 67–71.
Ruggeri, M, Bonetto, C, Lasalvia, A, Fioritti, A, de Girolamo, G, Santonastaso, P, Pileggi, F, Neri, G, Ghigi, D, Giubilini, F, Miceli, M, Scarone, S, Cocchi, A, Torresani, S, Faravelli, C, Cremonese, C, Scocco, P, Leuci, E, Mazzi, F, Pratelli, M, Bellini, F, Tosato, S, De Santi, K, Bissoli, S, Poli, S, Ira, E, Zoppei, S, Rucci, P, Bislenghi, L, Patelli, G, Cristofalo, D and Meneghelli, A (2015) Feasibility and effectiveness of a multi-element psychosocial intervention for first-episode psychosis: results from the cluster-randomized controlled GET UP PIANO trial in a catchment area of 10 million inhabitants. Schizophrenia Bulletin 41, 1192–1203.
Rush, JA, First, MB and Blacker, D (2008) Handbook of Psychiatric Measures. Washington, DC: American Psychiatric Association.
Sanchez-Gistau, V, Baeza, I, Arango, C, Gonzalez-Pinto, A, de la Serna, E, Parellada, M, Graell, M, Paya, B, Llorente, C and Castro-Fornieles, J (2015) The affective dimension of early-onset psychosis and its relationship with suicide. Journal of Child Psychology and Psychiatry 56, 747–755.
Sandhu, A, Ives, J, Birchwood, M and Upthegrove, R (2013) The subjective experience and phenomenology of depression following first episode psychosis: a qualitative study using photo-elicitation. Journal of Affective Disorders 149, 166–174.
Schultze-Lutter, F, Ruhrmann, S, Picker, H, von Reventlow, HG, Brockhaus-Dumke, A and Klosterkotter, J (2007) Basic symptoms in early psychotic and depressive disorders. British Journal of Psychiatry – Supplementum 51, s31–s37.
Shoval, G, Feld-Olspanger, J, Nahshoni, E, Gothelf, D, Misgav, S, Manor, I, Apter, A and Zalsman, G (2011) Suicidal behavior and related traits among inpatient adolescents with first-episode schizophrenia. Comprehensive Psychiatry 52, 596–599.
Siris, SG (2000) Depression in schizophrenia: perspective in the era of ‘atypical’ antipsychotic agents. American Journal of Psychiatry 157, 1379–1389.
Siris, SG and Bench, C (2003) Depression and schizophrenia. In Hirsch, SR and Weinberger, D (eds), Schizophrenia. Oxford, UK: Blackwell Publishing, pp. 142–167.
Slade, T, Johnston, A, Oakley Browne, MA, Andrews, G and Whiteford, H (2009) 2007 national survey of mental health and wellbeing: methods and key findings. Australian and New Zealand Journal of Psychiatry 43, 594–605.
Stouten, LH, Veling, W, Laan, W, van der Helm, M and van der Gaag, M (2014) Psychotic symptoms, cognition and affect as predictors of psychosocial problems and functional change in first-episode psychosis. Schizophrenia Research 158, 113–119.
Stowkowy, J, Addington, D, Liu, L, Hollowell, B and Addington, J (2012) Predictors of disengagement from treatment in an early psychosis program. Schizophrenia Research 136, 7–12.
Stroup, DF, Berlin, JA, Morton, SC, Olkin, I, Williamson, GD, Rennie, D, Moher, D, Becker, BJ, Sipe, TA and Thacker, SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283, 2008–2012.
Strous, RD, Maayan, R, Kaminsky, M, Blumensohn, R, Weizman, A and Spivak, B (2009) DHEA and DHEA-S levels in hospitalized adolescents with first-episode schizophrenia and conduct disorder: a comparison study. European Neuropsychopharmacology 19, 499–503.
Strous, RD, Bar, F, Keret, N, Lapidus, R, Kosov, N, Chelben, J and Kotler, M (2006) Analysis of Clinical Characteristics and Antipsychotic Medication Prescribing Practices of First-Episode Schizophrenia in Israel: A Naturalistic Prospective Study. Israel Journal of Psychiatry and Related Sciences 43, 2–9.
Tosato, S, Lasalvia, A, Bonetto, C, Mazzoncini, R, Cristofalo, D, De Santi, K, Bertani, M, Bissoli, S, Lazzarotto, L, Marrella, G, Lamonaca, D, Riolo, R, Gardellin, F, Urbani, A, Tansella, M and Ruggeri, M (2013) The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the psychosis incident cohort outcome study (PICOS). Journal of Psychiatric Research 47, 438–444.
Upthegrove, R, Birchwood, M, Ross, K, Brunett, K, McCollum, R and Jones, L (2010) The evolution of depression and suicidality in first episode psychosis. Acta Psychiatrica Scandinavica 122, 211–218.
Upthegrove, R, Ross, K, Brunet, K, McCollum, R and Jones, L (2014) Depression in first episode psychosis: the role of subordination and shame. Psychiatry Research 217, 177–184.
Upthegrove, R, Marwaha, S and Birchwood, M (2017) Depression and schizophrenia: cause, consequence, or trans-diagnostic issue? Schizophrenia Bulletin 43, 240–244.
Wassink, TH, Flaum, M, Nopoulos, P and Andreasen, NC (1999) Prevalence of depressive symptoms early in the course of schizophrenia. The American Journal of Psychiatry 156, 315–316.
Weissman, MM, Scholomskas, D, Pottenger, M, Prusoff, BA and Locke, BZ (1977) Assessing depressive symptoms in five psychiatric populations: a validation study. American Journal of Epidemiology 106, 203–214.
Zabala, A, Bustillo, M, Querejeta, I, Alonso, M, Mentxaka, O, Gonzalez-Pinto, A, Ugarte, A, Meana, J, Gutierrez, M and Segarra, R (2017) A pilot study of the usefulness of a single olanzapine plasma concentration as an indicator of early drug effect in a small sample of first-episode psychosis patients. Journal of Clinical Psychopharmacology 37, 569–577.
Zalsman, G, Carmon, E, Martin, A, Bensason, D, Weizman, A and Tyano, S (2003) Effectiveness, safety, and tolerability of risperidone in adolescents with schizophrenia: an open-label study. Journal of Child & Adolescent Psychopharmacology 13, 319–327.
Zhao, T, Park, T, Yang, J, Huang, G, Kim, M, Lee, K and Chung, Y (2012) Efficacy and safety of ziprasidone in the treatment of first-episode psychosis: an 8-week, open-label, multicenter trial. International Clinical Psychopharmacology 27, 184–190.